T
TregShield Bio pioneers precision-activated biologics designed to treat Immune and Inflammatory (I&I) diseases by restoring immune balance only at the site of disease. Their proprietary tissue-activable platform converts powerful therapies into disease-restricted biologics, minimizing systemic toxicity and off-target risks. This approach aims to achieve long-term remission for patients with I&I conditions through targeted, tissue-selective therapeutic delivery.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- TregShield Bio pioneers precision-activated biologics designed to treat Immune and Inflammatory (I&I) diseases by restoring immune balance only at the site of disease. Their proprietary tissue-activable platform converts powerful therapies into disease-restricted biologics, minimizing systemic toxicity and off-target risks. This approach aims to achieve long-term remission for patients with I&I conditions through targeted, tissue-selective therapeutic delivery.